ARTICLE SUMMARY:
Predetermined Change Control Plans have quickly evolved from an experimental concept to a real-life regulatory tool; Germany's DiGA Act has spurred digital therapeutics innovation; CMS' Steven Farmer addresses industry's TCET concerns; tips on reporting anticipated EU device shortages; and how to leverage new data usage techniques to streamline interactions with regulatory authorities.
